<bill session="117" type="h" number="8828" updated="2022-12-29T12:33:50Z">
  <state datetime="2022-09-14">REFERRED</state>
  <status>
    <introduced datetime="2022-09-14"/>
  </status>
  <introduced datetime="2022-09-14"/>
  <titles>
    <title type="display">FDA Ethics Act of 2022</title>
    <title type="short" as="introduced">FDA Ethics Act of 2022</title>
    <title type="official" as="introduced">To address potential conflicts of interest among entities serving as Food and Drug Administration contractors, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="K000382"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-09-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-09-14" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-09-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-12-21T16:06:12Z" status="Introduced in House">FDA Ethics Act of 2022

This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.</summary>
</bill>
